IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v40y2017i12d10.1007_s40264-017-0566-6.html
   My bibliography  Save this article

The Ribavirin Pregnancy Registry: An Interim Analysis of Potential Teratogenicity at the Mid-Point of Enrollment

Author

Listed:
  • Susan M. Sinclair

    (University of North Carolina Wilmington
    INC Research LLC)

  • Judith K. Jones

    (The Degge Group Ltd)

  • Richard K. Miller

    (University of Rochester)

  • Michael F. Greene

    (Harvard Medical School)

  • Paul Y. Kwo

    (Stanford University Medical Center)

  • Willis C. Maddrey

    (University of Texas Southwestern)

Abstract

Introduction Significant teratogenic effects have been demonstrated in all animal species exposed to ribavirin. Ribavirin is prescribed for chronic hepatitis C and is contraindicated in women who are pregnant and in the male sexual partners of women who are pregnant. Both sexes are advised to avoid pregnancy for 6 months after exposure. The Ribavirin Pregnancy Registry was established in 2003 to monitor pregnancy exposures to ribavirin for signals of possible human teratogenicity. Methods This voluntary registry enrolls pregnant women with prenatal exposure to ribavirin. Exposure is classified as direct—women taking ribavirin during pregnancy or the 6 months prior to conception—or indirect—women exposed through sexual contact, 6 months prior to or during pregnancy, with a man who is taking or has taken ribavirin in the past 6 months. Women are followed until delivery and infants for 1 year. When enrollment is complete, birth defect rates will be compared with the Metropolitan Atlanta Congenital Defects Program’s published rate of 2.67. Using data collected since inception in 2003 through February 2016, preliminary rates were calculated. Results The registry has enrolled 272 pregnant women, with 180 live births: there were seven birth defect cases among 85 directly exposed women [7/85 (8.2%) (95% confidence interval (CI) 3.4–16.2)] and four birth defect cases among 95 indirectly exposed women [4/95 (4.2%) (95% CI 1.2–10.4)]. Of the 11 infants, nine had structural defects and two had chromosomal anomalies. Patterns suggesting a common etiology or relationship with ribavirin exposure are not seen. Conclusion Based on the patterns of birth defects reported, preliminary findings do not suggest a clear signal of human teratogenicity for ribavirin. However, the current sample size is insufficient for definitive conclusions, and ribavirin exposure should be avoided during pregnancy and during the 6 months prior to pregnancy, in accordance with prescribing information. Clinical Trial Registration ClinicalTrials.gov identifier: NCT00114712.

Suggested Citation

  • Susan M. Sinclair & Judith K. Jones & Richard K. Miller & Michael F. Greene & Paul Y. Kwo & Willis C. Maddrey, 2017. "The Ribavirin Pregnancy Registry: An Interim Analysis of Potential Teratogenicity at the Mid-Point of Enrollment," Drug Safety, Springer, vol. 40(12), pages 1205-1218, December.
  • Handle: RePEc:spr:drugsa:v:40:y:2017:i:12:d:10.1007_s40264-017-0566-6
    DOI: 10.1007/s40264-017-0566-6
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-017-0566-6
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40264-017-0566-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Kevin Lang & Ana Nuevo-Chiquero, 2012. "Trends in Self-reported Spontaneous Abortions: 1970–2000," Demography, Springer;Population Association of America (PAA), vol. 49(3), pages 989-1009, August.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Vicente Soriano & Pablo Barreiro, 2017. "Is Ribavirin Teratogenic in Humans? No Evidence So Far," Drug Safety, Springer, vol. 40(12), pages 1163-1165, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Kevin Lang Jr. & Russell Weinstein Jr., 2015. "The Consequences of Teenage Childbearing before Roe v. Wade," American Economic Journal: Applied Economics, American Economic Association, vol. 7(4), pages 169-197, October.
    2. Eva Rye Johansen & Helena Skyt Nielsen & Mette Verner, 2024. "Teenage mothers and the next generation: benefits of delay?," Review of Economics of the Household, Springer, vol. 22(2), pages 451-476, June.
    3. Devon Gorry, 2019. "Heterogeneous Consequences of Teenage Childbearing," Demography, Springer;Population Association of America (PAA), vol. 56(6), pages 2147-2168, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:40:y:2017:i:12:d:10.1007_s40264-017-0566-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.